iiinova — where your digital self keeps evolving

Reposted by Juan Carlos López-Gil

Victor Javier @vjsanchez.bsky.social · 28/04/2026

🔬 Postdoc Opportunity – Molecular Oncology (UFV-H12O) We're looking for outstanding postdoctoral researchers to join our pancreatic cancer project funded by the Marie Skłodowska-Curie Actions (MSCA-PD) 🧪 Experimental OR 💻 Computational profiles welcome 👍 Interested? DM us or reach out to learn more!

023

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 25/04/2026

After 8 years, my computer is collapsing. Today I had to reinstall the OS. Anyone knows a good laptop with power to do bioinfo and is not expensive af? I’d rather prefer to change it before it totally dies…

000

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 24/04/2026

Ahora que llevo un mes inmerso en el mundo de la onco computacional, debo decir que hay cada truño de dataset por ahí publicado en revistas top, que es para llorar. No puede ser que mezcles single cell con single nuclei y digas que son dos subtipos distintos porque no integran… Amiga, date cuenta.

000

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 16/02/2026

New preprint alert! 🚨 High-fat diet imprints a macrophage-tumor CAMP-P2RX7 axis driving pancreatic cancer initiation, plasticity and metastasis www.biorxiv.org/content/10.6...

biorxiv.org

010

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 31/12/2025

Usually it is said that EMT and stemness are coupled mechanisms and for some authors, more EMT = more stemness but NO. EMT and stemness are parallel programs in some cases but independent. This article gives more insights into this: www.cell.com/iscience/ful...

cell.com

EMT-induced stem cell and mesenchymal programs can be decoupled via cell division and ESRP1-dependent mechanisms

Molecular biology; Cell biology

000

Reposted by Juan Carlos López-Gil

Guillaume Jacquemet @guijacquemet.bsky.social · 29/11/2025

Your periodic reminder that science is not done by a few selected "stars scientists". Science is done by hundred of thousands. Siloed money mean a few flashy discoveries and a lot of waste. Want to change things? Make funding accessible and stop funding calls with less than 2% success rate.

1220773

Reposted by Juan Carlos López-Gil

cniostopcancer.bsky.social @cniostopcancer.bsky.social · 10/09/2025

Los últimos avances en la investigación del cáncer de páncreas, en un congreso de la @fundacionareces.bsky.social coordinado por Mariano Barbacid y Carmen Guerra, con Francisco X. Real, Núria Malats y Vasiliki Liaki, de #CNIOStopCancer. 🔏Inscripciones gratis online t.co/IRqqi8XfFR

032

Reposted by Juan Carlos López-Gil

Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM) @iib.uam.es · 12/08/2025

El @csic.es difunde la concesión de la ayuda de proyectos sinérgicos de la Comunidad de Madrid a nuestro compañero Dr. Bruno Sainz junto con el Dr. Sergio Serrano-Villar @serranovillar.bsky.social del #IRYCIS Enhorabuena a los dos grupos de investigadores👏 @dicma-csic.bsky.social

022

Reposted by Juan Carlos López-Gil

bioRxiv Cancer Bio @biorxiv-cancer.bsky.social · 04/08/2025

A TARGETED COMBINATION THERAPY ACHIEVES EFFECTIVE PANCREATIC CANCER REGRESSION AND PREVENTS TUMOR RESISTANCE www.biorxiv.org/content/10.1101/202…

011

Reposted by Juan Carlos López-Gil

CSIC @csic.es · 05/08/2025

🔬 El proyecto del @iibm-csic-uam.bsky.social, con el #IRYCIS, investiga sobre el microbioma intestinal de pacientes con respuestas excepcionales a la inmunoterapia 👉 El objetivo final es descubrir fármacos para superar la resistencia en tumores refractarios a inmunoterapia

033

Reposted by Juan Carlos López-Gil

cniostopcancer.bsky.social @cniostopcancer.bsky.social · 07/07/2025

@juancarloslpz13.bsky.social estudia mutaciones en las células madre tumorales del tipo más frecuente y agresivo de cáncer de páncreas, el adenocarcinoma ductal, para lograr un diagnóstico más temprano y contribuir a desarrollar fármacos tanto prevenirlo como para tratarlo mejor.

121

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 27/06/2025

Thank you Victor for the kind invitation and the opportunity to talk about my favourite topic!

020

Reposted by Juan Carlos López-Gil

Victor Javier @vjsanchez.bsky.social · 26/06/2025

Day 2 of our pancreatic cancer course was incredible! So excited about the amazing scientific content we covered today. From cancer stem cells to immune microenvironment - what a journey! 🔬✨ 🧪@ufvmadrid.bsky.social

121

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 26/06/2025

Giving talks is one of the parts of this job that I love the most! Today twice. First, for the CNIO Friends initiative which support my postdoctoral work. Later, at Universidad Francisco de Vitoria about immune suppression in PDAC. What a joy to share science!!

010

Reposted by Juan Carlos López-Gil

Victor Javier @vjsanchez.bsky.social · 25/06/2025

Amazing first day of our pancreatic cancer summer course! Great attendance with young professionals eager to learn more about this disease - they are the future of better treatments 🔬

101

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 17/06/2025

Fresh from the oven!! Our latest review published in @chp-pivot.bsky.social about the origin of PDAC CSCs and their inner and outer determinants by Diego Navarro and myself. A little bit of inflammation, a little bit of CIN, tons of stemness!! Enjoy!! www.pivotscipub.com/chp/2/2/0010

031

Reposted by Juan Carlos López-Gil

VickySanzMoreno @vickysanzmoreno.bsky.social · 15/05/2025

Exciting opportunity: Emerging Clinical Academic Fellowship scheme, newly launched by CRIS Cancer Foundation and the ICR We are offering a project within this scheme, please share! 👇 👇 🤩 www.icr.ac.uk/study-and-ca...

icr.ac.uk

Opportunities for postdoctoral clinical fellows - The Institute of Cancer Research, London

CRIS Cancer Foundation and the ICR are offering 2-3 year fellowships to support the development of outstanding early postdoctoral stage clinical researchers.

033

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 29/04/2025

Saying goodbye to beautiful London after a terrific @transpan_cost meeting. So glad to present new data from the Exp Oncology lab and meet old and new friends fighting for new opportunities against PDAC.

020

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 10/04/2025

Two sides of scientific life lately. Yesterday, in the mountains in a bioinformatics retreat organised by CIBERONC, and today, at Fundación Ramón Areces for the CRIS Scientific Symposium.

010

Reposted by Juan Carlos López-Gil

Cold Spring Harbor Laboratory @cshlnews.bsky.social · 02/04/2025

Pancreatic cancer is projected to become the second-deadliest cancer by 2030, but new research from CSHL may offer a path forward. Professor David Tuveson & Research Investigator Claudia Tonelli have discovered a way to intercept pancreatic cancer before it fully forms.

cshl.edu

In pancreatic cancer, a race against time | Cold Spring Harbor Laboratory

AI generated voice with David Tuveson’s actual voice Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it’s diagnosed, it’s often difficult to treat. So, for bo...

085

Reposted by Juan Carlos López-Gil

ASEICA @aseica.bsky.social · 26/03/2025

📢‼️ Abierta la convocatoria de la VI Ayuda @fundacionfero.bsky.social-ASEICA para el Talento Joven en Cáncer 👨‍🔬🔬80.000€ 🎯: Promover la investigación oncológica de personal joven investigador en España 🗓️Revisa los plazos de presentación ➡️ Cierre primera fase: 6/04👇 www.aseica.es/la-fundacion...

aseica.es

La Fundación FERO y ASEICA renuevan su colaboración para apoyar a nuevos grupos de investigación en oncología

Estas entidades convocan una ayuda orientada a jóvenes científicos y científicas que están iniciando sus grupos cualquier ámbito de la investigación en cáncer.La cuantía es de 80.000€ Madrid, marzo...

012

Reposted by Juan Carlos López-Gil

Denis Wirtz @deniswirtz.bsky.social · 26/03/2025

Yup

1457

Reposted by Juan Carlos López-Gil

ASEICA @aseica.bsky.social · 25/03/2025

🔬¿Eres postdoc e investigas en cáncer? Te interesa‼️ 📢 Isabel Fabregat (@idibell.bsky.social) "Consejos para triunfar en convocatorias postdoctorales de financiación" 📅Mañana miércoles, 26-M, 9h. 📩aseicapostdocs@gmail.com Coordinan: Sara Manzano & Vanesa Cepas Lopez #ASEICAJoven

012

Reposted by Juan Carlos López-Gil

S. García-Silva @s-garciasilva.bsky.social · 27/02/2025

The spirit of multidisciplinary work in just one man, Wolfgang von Goethe. Here it is an illustration from Zur Farbenlehre (Theory of Colours).

031

Reposted by Juan Carlos López-Gil

Amaia Cipitria @amaiacipitria.bsky.social · 19/02/2025

📢 Are you a cancer researcher willing to strengthen ties with Spain? Are you looking for new opportunities or collaboration partners? Or are you in Spain searching for a lab abroad? Then take a look at #ASEICAInternacional and sign up here👇 bit.ly/4geGD0e. Please share the link! @aseica.bsky.social

077

Reposted by Juan Carlos López-Gil

Victor Javier @vjsanchez.bsky.social · 16/02/2025

3️⃣ Key findings ✅ ELOVL6 controls membrane stiffness and permeability in PDAC cells. ✅ Its inhibition increases drug uptake and enhances Abraxane sensitivity. ✅ Inhibiting ELOVL6 slows tumor growth in vivo, improving survival. #CancerBiology #TargetedTherapies #PancreaticCancer 🧪

112

Reposted by Juan Carlos López-Gil

@XRBustelo @xrbustelo.bsky.social · 15/02/2025

✅👉Here we go again: 2️⃣nd RAS MEETING in Salamanca to celebrate the 2️⃣5️⃣th Anniversary of the ⁦‪@ciccancer 👉 Great roster of speakers and exceptional science ‼️joing us‼️ 📅 8️⃣-1️⃣0️⃣ October 2️⃣0️⃣2️⃣5️⃣ ⁦‪@ASEICAnews‬⁩ ⁦‪@EACRnews‬⁩ ⁦‪@NIH‬⁩ ⁦‪⁦‪@SEBBM_es‬

095

Reposted by Juan Carlos López-Gil

ASEICA @aseica.bsky.social · 04/02/2025

🔬✨La Asociación Española de Investigación sobre el Cáncer ya está en Bluesky✨🔬 Somos➕de 1700 miembros básicos y clínicos comprometidos con avanzar en la prevención y diagnóstico del cáncer, innovar en tratamientos y mejorar la calidad de vida de los pacientes ¡Únete! www.aseica.es #WorldCancerDay

3147

Reposted by Juan Carlos López-Gil

Casanova-Acebes Lab @casanova-acebes.bsky.social · 08/02/2025

Honored to discuss on #TAMs targeting in PDAC. Check us out: urldefense.com/v3/__http://..., and the fantastic findings by Russell et al., here t.co/EBpU14LmOH

urldefense.com

011

Reposted by Juan Carlos López-Gil

S. García-Silva @s-garciasilva.bsky.social · 06/02/2025

Es una gran experiencia participar en #CONOCELAS de la @aseica.bsky.social y promover el dia de la mujer y la niña en la Ciencia. Gracias al #instituto_cardenal_cisneros, y gracias a #Rocio_Codes, #Jose_deJuan su directora #Mar_Ruiz_Calero y a los alumnos de 4º y 1ºESO y 1º de Bachillerato!

133

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 05/02/2025

Como siempre, #CONOCELAS siendo una actividad imprescindible en estas vísperas del 11F. ¡A tope, compañeras de @aseica.bsky.social!

042

Reposted by Juan Carlos López-Gil

Marisol Soengas @msmelanoma.bsky.social · 22/12/2024

Yeah! So thankful to science!!! A year ago I started on treatment. By April, I could not run 1K… Today I crossed the line of 11K. A warm hug to all so many struggling with cancer 💙 #AsociacionEspañolaContraElCancer @aseica.bsky.social

3545

Reposted by Juan Carlos López-Gil

Patricia Altea-Manzano @alteamanzanolab.bsky.social · 13/12/2024

We are hiring! We are looking for a motivated postdoctoral fellow to work on an exciting project on #Metastasis and #HighFatDiet at #CABIMER in the beautiful city of Seville (Spain). Join us! More info 👇

02011

Reposted by Juan Carlos López-Gil

EACR - European Association for Cancer Research @helloeacr.bsky.social · 12/12/2024

Let’s keep the spirit of curiosity alive and thriving in cancer research! #KeepResearchCurious ✨

0166

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 07/12/2024

Not scientific BUT how beautiful is Bern during Advent time?? 🥰🇨🇭

010

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 29/11/2024

Very excited with the latest results from my thesis. I cannot wait to share this new work and to send the manuscript to our collaborators to have their input.

010

Juan Carlos López-Gil @juancarloslpz13.bsky.social · 27/11/2024

Tired and thankful for this visit to the 2nd home science gave me. 🇨🇭 is amazing! And if you can share it with friends, it’s even better ☺️

010

Reposted by Juan Carlos López-Gil

Anna Obenauf @obenaufa.bsky.social · 27/11/2024

1/23 Big news for the #ObenaufLab! So excited to finally share our new study providing another puzzle piece, why immunotherapy fails in many tumors, now out in @Nature 🧵👇 www.nature.com/articles/s41...

47558141